Literature DB >> 23563135

Malignant bileaflet mitral valve prolapse syndrome in patients with otherwise idiopathic out-of-hospital cardiac arrest.

Chenni S Sriram1, Faisal F Syed2, M Eric Ferguson1, Jonathan N Johnson1, Maurice Enriquez-Sarano2, Frank Cetta3, Bryan C Cannon1, Samuel J Asirvatham3, Michael J Ackerman4.   

Abstract

OBJECTIVES: The aim of this study was to investigate the prevalence of mitral valve prolapse (MVP) and its association with ventricular arrhythmias in a cohort with "unexplained" out-of-hospital cardiac arrest.
BACKGROUND: Ventricular arrhythmias are an important cause of sudden unexpected death in the young. The role of MVP in sudden unexpected death remains controversial.
METHODS: Of 1,200 patients evaluated between July 2000 and December 2009 in the Mayo Clinic's Long QT Syndrome/Genetic Heart Rhythm Clinic, all 24 (16 women, median age 33.5 years) with idiopathic out-of-hospital cardiac arrest (i.e., negative for ischemia, cardiomyopathy, and channelopathy) were reviewed.
RESULTS: All 24 patients had implantable cardioverter-defibrillators (ICDs). Out-of-hospital cardiac arrest was the sentinel event in 22 (92%). Bileaflet MVP was found in 10 (42%). Compared with patients with normal mitral valves, patients with bileaflet MVP: 1) were over-represented by women (9 of 10 [90%] vs. 7 of 14 [50%], p = 0.04); 2) had a higher prevalence of biphasic or inverted T waves (7 of 9 [77.8%] vs. 4 of 14 [29%], p = 0.04); and 3) on Holter interrogation had higher prevalence of ventricular bigeminy (9 of 9 [100%] vs. 1 of 10 [10%], p < 0.0001), ventricular tachycardia (7 of 9 [78%] vs. 1 of 10 [10%], p = 0.006), and premature ventricular contractions originating from the outflow tract alternating with the papillary muscle or fascicular region (7 of 9 [78%] vs. 2 of 10 [20%], p = 0.02). Over a median 1.8 years (range: 0.1 to 11.9 years) from ICD placement, 13 of 24 patients (54%) received appropriate ventricular fibrillation-terminating ICD shocks. Only bileaflet MVP was associated with ventricular fibrillation recurrences requiring ICD therapy on follow-up (logistic regression odds ratio: 7.2; 95% confidence interval: 1.1 to 48; p = 0.028).
CONCLUSIONS: The authors describe a "malignant" subset of patients with MVP who experienced life-threatening ventricular arrhythmias. This phenotype is characterized by bileaflet MVP, female sex, and frequent complex ventricular ectopic activity, including premature ventricular contractions of the outflow tract alternating with papillary muscle or fascicular origin.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23563135     DOI: 10.1016/j.jacc.2013.02.060

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  59 in total

Review 1.  Ablating Premature Ventricular Complexes: Justification, Techniques, and Outcomes.

Authors:  Amit Noheria; Abhishek Deshmukh; Samuel J Asirvatham
Journal:  Methodist Debakey Cardiovasc J       Date:  2015 Apr-Jun

Review 2.  Mitral valve prolapse: an underestimated cause of sudden cardiac death-a current review of the literature.

Authors:  Michael Spartalis; Eleni Tzatzaki; Eleftherios Spartalis; Antonios Athanasiou; Demetrios Moris; Christos Damaskos; Nikolaos Garmpis; Vassilis Voudris
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

Review 3.  The infrahisian conduction system and endocavitary cardiac structures: relevance for the invasive electrophysiologist.

Authors:  Faisal F Syed; Jo Jo Hai; Nirusha Lachman; Christopher V DeSimone; Samuel J Asirvatham
Journal:  J Interv Card Electrophysiol       Date:  2013-12-10       Impact factor: 1.900

Review 4.  New Concepts in Sudden Cardiac Arrest to Address an Intractable Epidemic: JACC State-of-the-Art Review.

Authors:  Sanjiv M Narayan; Paul J Wang; James P Daubert
Journal:  J Am Coll Cardiol       Date:  2019-01-08       Impact factor: 24.094

5.  Role of genetic heart disease in sentinel sudden cardiac arrest survivors across the age spectrum.

Authors:  John R Giudicessi; Michael J Ackerman
Journal:  Int J Cardiol       Date:  2018-05-30       Impact factor: 4.164

6.  Feature tracking myocardial strain analysis in patients with bileaflet mitral valve prolapse: relationship with LGE and arrhythmias.

Authors:  Marco Gatti; Anna Palmisano; Antonio Esposito; Stefano Fiore; Caterina Beatrice Monti; Alessandro Andreis; Lorenzo Pistelli; Pasquale Vergara; Laura Bergamasco; Carla Giustetto; Francesco De Cobelli; Paolo Fonio; Riccardo Faletti
Journal:  Eur Radiol       Date:  2021-04-19       Impact factor: 5.315

7.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Saenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  J Interv Card Electrophysiol       Date:  2020-10       Impact factor: 1.900

Review 8.  The spectrum of epidemiology underlying sudden cardiac death.

Authors:  Meiso Hayashi; Wataru Shimizu; Christine M Albert
Journal:  Circ Res       Date:  2015-06-05       Impact factor: 17.367

Review 9.  Mitral Valve Pathology.

Authors:  Gregory A Fishbein; Michael C Fishbein
Journal:  Curr Cardiol Rep       Date:  2019-05-23       Impact factor: 2.931

Review 10.  Sudden cardiac death from structural heart diseases in adults: imaging findings with cardiovascular computed tomography and magnetic resonance.

Authors:  Song Soo Kim; Sung Min Ko; Sang Il Choi; Bo Hwa Choi; Arthur E Stillman
Journal:  Int J Cardiovasc Imaging       Date:  2016-05-02       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.